Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Financial toxicity may be common in gynecologic cancer patients

Key clinical point: Financial toxicity may be common in gynecologic cancer patients starting a new line of therapy.

Major finding: Financial toxicity was reported by 54% of 121 gynecologic cancer patients surveyed.

Study details: Online and in-person surveys of 121 patients

Disclosures: The speaker reported no disclosures.

Citation:

Liang M et al. SGO 2019. Abstract 8.